Suture Anchor Devices Market Size & Growth Forecast 2026–2035, By Segments (Product, Tying Type, End-use, Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Suture Anchor Devices Market size was more than USD 843.91 Million in 2025 and is set to grow at a 3.6% CAGR between 2026 and 2035, surpassing USD 1.2 Billion by 2035. The industry revenue for 2026 is calculated at USD 869.73 million.

• Base Year Value (2025): USD 843.91 Million
• CAGR (2026-2035): 3.6%
• Forecast Year Value (2035): USD 1.2 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Suture Anchor Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 43.46% of the market in 2025, driven by high orthopedic procedure volumes, widespread arthroscopic surgery adoption, and well-established hospital and ambulatory surgical infrastructure.
  • Asia Pacific is forecast to grow at a 4.1% CAGR due to expanding orthopedic care access, increasing sports injury treatments, and broader adoption of minimally invasive repair techniques.

• Segment Momentum:

  • Non-absorbable anchors accounted for 57.86% of the market in 2025 due to their reliable long-term fixation, consistent mechanical performance, and widespread surgeon familiarity in orthopedic soft tissue repair procedures.
  • Knotted suture anchors are gaining momentum because many surgeons continue to value tactile tension adjustment and established repair techniques, supporting adoption where conventional fixation methods remain preferred.

• Market Expansion Drivers:

  • Rising sports injuries and orthopedic trauma increasing demand for soft tissue fixation devices.
  • Aging population driving higher incidence of tendon and ligament repair procedures globally.
  • Advancements in minimally invasive arthroscopic techniques improving surgical adoption rates.

• Leading Market Participants:

  Leading companies in the suture anchor devices market include Arthrex, Inc. (United States), Smith & Nephew plc (United Kingdom), Stryker Corporation (United States), Zimmer Biomet Holdings, Inc. (United States), CONMED Corporation (United States), Johnson & Johnson Services, Inc. (United States), Enovis Corporation (United States), Medtronic plc (Ireland), Parcus Medical, LLC (United States), Medacta International SA (Switzerland).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 843.91 Million
  • Projected Market Size: USD 1.2 Billion by 2035
  • Growth Forecasts: 3.6% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Non-absorbable (Product) | Knotless (Tying Type) | Hospitals (End-use) | Metallic Suture Anchor (Material)
  • Emerging Opportunity Segment: Absorbable (Product) | Knotted Suture Anchors (Tying Type) | Ambulatory Surgical Centers (End-use) | Bio-absorbable Suture Anchor (Material)

Market Growth Drivers and Industry Trends

Rising sports injuries and orthopedic trauma increasing demand for soft tissue fixation devices

A steady increase in sports-related injuries and orthopedic trauma is reinforcing market demand for the suture anchor devices market by expanding the volume of rotator cuff, labral, Achilles, and ligament repair procedures that require secure soft tissue-to-bone fixation. In practice, surgeons treating acute tears and joint instability often favor fixation systems that can be deployed efficiently and provide reliable anchoring in anatomically constrained repair sites, which keeps suture anchors closely tied to procedure growth in sports medicine and trauma care. As hospitals and ambulatory surgery centers handle a larger share of these cases, procurement increasingly centers on anchor designs that support faster repair workflows, predictable handling, and compatibility with arthroscopic techniques, contributing to market size growth through higher procedure-linked utilization.

Aging population driving higher incidence of tendon and ligament repair procedures globally

Demographic aging is supporting market expansion in the suture anchor devices market because older patients experience a greater incidence of degenerative tendon tears, chronic shoulder instability, and age-related soft tissue deterioration that often progresses from conservative management to surgical repair. This shifts demand toward devices suited for complex tissue quality and variable bone conditions, prompting surgeons to select anchor systems that can improve fixation confidence during rotator cuff, biceps, and other tendon reattachment procedures. The practical effect is not only a broader procedural base but also sustained purchasing demand from orthopedic departments managing a rising caseload of repair surgeries linked to long-term musculoskeletal degeneration.

Advancements in minimally invasive arthroscopic techniques improving surgical adoption rates

The refinement of arthroscopic repair techniques is increasing market penetration for the suture anchor devices market by making soft tissue fixation procedures less invasive, more standardized, and more acceptable to both surgeons and patients. As arthroscopy reduces tissue disruption, shortens recovery expectations, and supports treatment in outpatient settings, surgeons are more willing to intervene earlier in shoulder, hip, knee, and ankle repairs where anchor-based fixation is central to the procedure. This practical shift influences product development and purchasing decisions toward anchors with better insertion control, smaller profiles, and instrument compatibility, supporting market development as procedural adoption rises alongside the continued preference for minimally invasive orthopedic surgery.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising sports injuries and orthopedic trauma increasing demand for soft tissue fixation devices	1.90%	High	North America, Europe, Asia Pacific	High	Near Term
Aging population driving higher incidence of tendon and ligament repair procedures globally	1.80%	High	North America, Europe	High	Near Term
Advancements in minimally invasive arthroscopic techniques improving surgical adoption rates	1.40%	Moderate	Global	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 43.46% share of the suture anchor devices market in 2025, supported by the region’s high volume of orthopedic and sports medicine procedures, broad adoption of arthroscopic repair techniques, and established hospital and ambulatory surgery center infrastructure. Its leadership is strengthened by routine use of advanced fixation products in shoulder, knee, and soft tissue repair, where surgeon familiarity, procedural standardization, and access to specialized care sustain steady device demand across clinical settings.

Asia Pacific is projected to expand at a 4.1% CAGR over the forecast period, with growth in the suture anchor devices market being propelled by rising access to orthopedic treatment, increasing surgical intervention for sports injuries and degenerative joint conditions, and the ongoing buildout of specialist care capacity. Adoption is accelerating as more providers incorporate minimally invasive repair approaches into practice, creating stronger demand for procedural devices that support faster intervention and broader treatment availability across developing healthcare systems.

Key Country Insights

United States

Sports Medicine Innovation

The U.S. suture anchor devices market benefits from continued demand for advanced orthopedic and sports medicine procedures. Healthcare providers increasingly adopt devices that simplify surgical techniques while supporting reliable soft tissue fixation.

Japan

Minimally Invasive Repair

Japan continues adopting suture anchor devices for arthroscopic procedures that support less invasive soft tissue repair. Japanese healthcare providers emphasize precision, implant reliability, and improved recovery pathways for orthopedic patients.

South Korea

Arthroscopy Procedure Growth

South Korea is expanding the use of suture anchor devices as hospitals increase the availability of advanced arthroscopic orthopedic procedures. Clinicians prioritize implants that combine dependable fixation with efficient surgical handling.

Germany

Orthopedic Precision Solutions

Germany focuses on suture anchor devices that deliver consistent fixation performance in shoulder, knee, and other orthopedic procedures. Medical device manufacturers continue refining implant materials and surgical instrumentation to enhance procedural efficiency.

France

Soft Tissue Reconstruction

France emphasizes suture anchor devices for ligament and tendon repair across sports medicine and orthopedic specialties. Healthcare providers increasingly evaluate implants based on procedural consistency, clinical performance, and compatibility with minimally invasive techniques.

Italy

Surgical Technique Enhancement

Italy continues strengthening the use of suture anchor devices in orthopedic surgery through greater adoption of arthroscopic repair techniques. Medical centers prioritize high-quality fixation systems that support efficient procedures and dependable clinical outcomes.

Segment Leadership and Growth Trends

  Product Segment Analysis: Non-absorbable (Largest Segment) vs Absorbable (Fastest-Growing Segment)

Within the suture anchor devices market, non-absorbable products accounted for a 57.86% share in 2025, reflecting their continued leadership in procedures where long-term fixation reliability remains a central clinical requirement. Their position is sustained by surgeon familiarity, consistent mechanical performance, and broad use in orthopedic soft tissue repair where durable anchor stability is prioritized over material resorption. This established procedural confidence helps non-absorbable anchors retain the leading share across routine and high-demand surgical settings in the suture anchor devices market.

Absorbable anchors are emerging as the fastest-growing product type in the suture anchor devices market as clinical preference increasingly shifts toward materials that reduce the long-term presence of permanent implants. Growth is being reinforced through rising interest in post-surgical healing profiles that align with gradual material breakdown, particularly in cases where implant permanence may be less desirable. Compared with non-absorbable alternatives, absorbable anchors are gaining momentum because they better match evolving surgeon and patient expectations around tissue integration and implant management over time.

Tying Type Segment Analysis: Knotless (Largest Segment) vs Knotted Suture Anchors (Fastest-Growing Segment)

By 2025, knotless anchors held the largest share in the suture anchor devices market, reinforced through their fit with procedural efficiency and reproducibility in arthroscopic repair. Their leadership reflects practical operating room advantages, including reduced knot management complexity and more streamlined soft tissue fixation during surgery. These workflow benefits make knotless systems a widely adopted choice in the suture anchor devices market, helping them maintain the leading share across high-volume orthopedic applications.

Knotted suture anchors are registering the fastest growth in the suture anchor devices market as surgeons continue to use them in cases where knot control and established repair techniques remain important to procedural preference. Their momentum is tied to continued demand in surgical settings that value tactile tension adjustment and familiarity with conventional fixation methods. Relative to knotless systems, knotted suture anchors are seeing wider adoption where technique-specific requirements and surgeon comfort with traditional repair approaches support renewed adoption.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Absorbable, Non-absorbable	Non-absorbable	Absorbable
Tying Type	Knotted Suture Anchors, Knotless	Knotless	Knotted Suture Anchors
End-use	Hospitals, Ambulatory Surgical Centers, Clinics	Hospitals	Ambulatory Surgical Centers
Material	Metallic Suture Anchor, Bio-absorbable Suture Anchor, Others	Metallic Suture Anchor	Bio-absorbable Suture Anchor

Competitive Landscape and Market Positioning

Major players in the suture anchor devices market:

1. Arthrex Inc. (United States)

2. Smith & Nephew plc (United Kingdom)

3. Stryker Corporation (United States)

4. Zimmer Biomet Holdings Inc. (United States)

5. CONMED Corporation (United States)

6. Johnson & Johnson Services Inc. (United States)

7. Enovis Corporation (United States)

8. Medtronic plc (Ireland)

9. Parcus Medical LLC (United States)

10. Medacta International SA (Switzerland)

The suture anchor devices market is progressing with increasing adoption of advanced orthopedic fixation technologies. Innovation focuses on improving anchoring strength and surgical precision. The suture anchor devices market is also influenced by demand for minimally invasive orthopedic procedures. Continuous development efforts are enhancing procedural reliability and recovery outcomes.

Industry Development/News

Company Name	Date	Key Development
Parcus Medical; KeriMedical; Magnesium Development Company; SINTX Technologies; University of Pittsburgh; DePuy Synthes	May-24	Multiple organizations including Parcus Medical, KeriMedical, and DePuy Synthes are engaged in development of suture anchor devices across early and late-stage programs aimed at improving soft tissue fixation in orthopedic procedures. The activity reflects broad innovation across biomaterials, implant design, and surgical fixation technologies targeting enhanced clinical performance in orthopedic surgery.
Anika Therapeutics, Inc.	Sep-23	Anika Therapeutics showcased its orthopedic portfolio at the Orthopaedic Summit Annual Meeting, including the RevoMotion Reverse Shoulder Arthroplasty System, Integrity Implant System, and X-Twist Fixation System. The X-Twist suture anchors support expansion of the company’s fixation technologies in response to rising demand for advanced orthopedic implant solutions.
Stryker	Dec-22	Stryker launched the Citrefix suture anchor system for foot and ankle procedures using Citregen bioresorbable biomaterial designed to support bone regeneration. The product enhances Stryker’s orthopedic fixation portfolio by combining implant stability with bioresorbable properties that align with natural healing processes.
Arthrex, Inc.	Jan-24	Arthrex expanded its knotless suture anchor product lines for shoulder reconstruction procedures, strengthening its orthopedic fixation portfolio. The expansion enhances minimally invasive surgical options and reinforces the company’s competitive position in soft tissue repair and sports medicine applications.
Smith & Nephew	Jan-25	Smith & Nephew introduced advanced bio-composite fixation systems for arthroscopic surgical procedures, strengthening its orthopedic implant portfolio. The development reflects ongoing advancement in biomaterial-based fixation technologies aimed at improving surgical outcomes in soft tissue and joint reconstruction applications.
Zimmer Biomet Holdings, Inc.	Jan-23	Zimmer Biomet increased investment in robotic-assisted orthopedic surgery technologies, supporting enhanced precision in implant placement and surgical procedures. The initiative strengthens the company’s broader orthopedic ecosystem by integrating digital and robotic capabilities with implant-based treatment solutions.
Stryker	Jan-24	Stryker expanded its minimally invasive sports medicine implant offerings, reinforcing its orthopedic fixation portfolio. The expansion supports growing demand for arthroscopic procedures and enhances the company’s competitive positioning in soft tissue repair and sports medicine device markets.
CONMED Corporation	Jan-25	CONMED launched enhanced arthroscopic fixation devices with improved pullout strength, strengthening its surgical implant portfolio. The development reflects advancements in mechanical performance of fixation systems used in minimally invasive orthopedic and sports medicine procedures.